Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Watching Imunon, Zacks Small-Cap Research Sets $17 Price Valuation

https://s27.q4cdn.com/906368049/files/News/2022/Zacks_SCR_Research_11302022_IMNN_Bautz.pdf
byBenzinga Newsdesk
November 30, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

https://s27.q4cdn.com/906368049/files/News/2022/Zacks_SCR_Research_11302022_IMNN_Bautz.pdf

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Exclusive: ‘People Want To Hear About Revenue Now, Not Bulls***’ — Why Citron Research Is Short Luminar Technologies Stock

By Chris Katje
January 6, 4:34 PM
One of the themes of the last two years has been a growing number of lidar technology companies going public — many chose the SPAC route. A hedge fund is now taking on one of those companies and shared with Benzinga exactly why.

INVZ